Stock comparison
AstraZeneca
AZN$267.63BHealthcare Market cap, Sector
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$106.55BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
AZN 07 SANOFICONR.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
AZN0wins
7winsSANOFICONR.NS
60C
B78
69C
A89
71B
B83
56D
B77
47D
A91
58D
A86
51D
A85
Side-by-side metrics
| Metric | AZN | SANOFICONR.NS |
|---|---|---|
| Market cap | Winner: $267.63B | $106.55B |
| P/E (TTM) | Winner: 26.2x | 44.2x |
| EV/EBIT | Winner: 20.8x | 31.8x |
| ROIC (TTM) | 14.59% | 59.15% Winner |
| Gross margin | Winner: 81.9% | 68.13% |
| Net margin | 17.41% | 27.35% Winner |
| Revenue CAGR 5y | 9.82% | 27.01% Winner |
| EPS CAGR 5y | Winner: 45.9% | 20.67% |
| Debt / Equity | 0.6x | 0.1x Winner |
| Dividend yield | 1.72% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
AZN leads on
- Market cap$267.63Bvs $106.55B+60%
- EPS CAGR 5y45.9%vs 20.67%+55%
- P/E (TTM)26.2xvs 44.2x+41%
- EV/EBIT20.8xvs 31.8x+35%
SANOFICONR.NS leads on
- Debt / Equity0.1xvs 0.6x+89%
- ROIC (TTM)59.15%vs 14.59%+75%
- Revenue CAGR 5y27.01%vs 9.82%+64%
- Net margin27.35%vs 17.41%+36%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.